Anaplasma phagocytophilum is a Gram-negative bacterium responsible for human granulocytic anaplasmosis (HGA) in people, tick-borne fever (TBF) in ruminants, equine granulocytic anaplasmosis (EGA) in horses, and granulocytic anaplasmosis (GA) in dogs and cats [1]. In the Palearctic region, the dominant genetic variants of A. phagocytophilum are transmitted by I. ricinus and I. persulcatus, while I. scapularis and I. pacificus are known vectors in the Nearctic region [2, 3].
Genetic variants of A. phagocytophilum in North America and Europe differ in host preference and clinical symptoms, with TBF and EGA dominant in Europe and HGA dominant in North America [4, 5]. The genetic diversity of European strains of A. phagocytophilum of the different origin was demonstrated by phylogenetic analyses of genes such as groEL [6–8], ankA [4], and msp4 [9]. Different target genes led to different names of the genetic variants and consequently different terminology, such as ecotype (groEL), cluster (ankA and groEL), and genotype (msp4) [4, 10].
The heat shock operon groESL contains two genes encoding the chaperone proteins groES and groEL, as well as the intergenic region. A 5' fragment of the groEL gene has been widely used for genotyping A. phagocytophilum, especially those from Europe [11–13]. Currently, based on groEL, four ecotypes and eight clusters with different pathogenicity and geographical origin are distinguished [7, 8].
The variable ankA gene encodes the ankyrin repeat-containing protein AnkA (153–160 kDa). The ankA gene differentiates variants corresponding with the species of their animal hosts and exhibits higher sequence variability compared to that of 16S rDNA, the groEL, and msp4 genes [3]. Association of genetic variants was found among vertebrate hosts, tick vectors, and geographic locations. Regardless of the gene used for analysis, infected humans, whether in Europe or the Americas, appear to share related strains belonging to the same genetic group [5, 14].
The number of HGA cases reported in the USA has been steadily increasing since the disease became reportable; from 348 in 2000 to 5,762 cases in 2017 (https://www.cdc.gov/anaplasmosis/stats/index.html). In Europe, the total annual number of HGA cases has not exceeded 300 [2, 15]. Several HGA cases were reported also in Canada, Russia, China, Taiwan, South Korea, and Japan (reviewed by Rar et al. 2021). According to the National Institute of Public Health in the Czech Republic, 53 cases of HGA were reported between 2007 and 2017; however, in the seroprevalence study from 2014, specific antibodies were detected in 34 of 314 individuals tested [16]. Furthermore, recently, 12.6% of 103 patients with clinical symptoms persisting after antibiotic treatment of diagnosed Lyme disease were positive for A. phagocytophilum IgG antibodies [17]. Similar rates of seroprevalence were reported in other European countries including Norway, Sweden, and Poland, where Anaplasma antibodies were detected in 11.0%, 12.0% and 11.8% population, respectively (17). The disease is likely greatly underdiagnosed due to nonspecific flu-like symptoms such as fever, headache, and myalgias that usually resolve without treatment [1]. If the immune system fails and the infection is left untreated, the disease can cause life-threatening symptoms such as respiratory failure, severe gastrointestinal bleeding, renal failure, and liver damage [19]. Although surveillance reports of A. phagocytophilum in tick vectors are increasing worldwide, the epidemiological risk of infection by this pathogen is underestimated [20]. Detection of pathogens in blood-feeding ticks shows the risk of human exposure better than studies on foraging ticks [21]. In this context, the main objective of our study was to investigate the genetic diversity of A. phagocytophilum in ticks attached to people in the Czech Republic nationwide.